Post-natal treatment by a blood-brain-barrier permeable calpain inhibitor, SNJ1945 rescued defective function in lissencephaly

  • Shiori Toba
  • , Yasuhisa Tamura
  • , Kanako Kumamoto
  • , Masami Yamada
  • , Keizo Takao
  • , Satoko Takai
  • , Tsuyoshi Miyakawa
  • , Yosky Kataoka
  • , Mitsuyoshi Azuma
  • , Kiyoshi Hayasaka
  • , Masano Amamoto
  • , Keiko Tominaga
  • , Anthony Wynshaw-Boris
  • , Hideki Wanibuchi
  • , Yuichiro Oka
  • , Makoto Sato
  • , Mitsuhiro Kato
  • , Shinji Hirotsune

Research output: Contribution to journalArticlepeer-review

20 Citations (Scopus)

Abstract

Toward a therapeutic intervention of lissencephaly, we applied a novel calpain inhibitor, SNJ1945. Peri-natal or post-natal treatment with SNJ1945 rescued defective neuronal migration in Lis1+/− mice, impaired behavioral performance and improvement of 18F-FDG uptake. Furthermore, SNJ1945 improved the neural circuit formation and retrograde transport of NFG in Lis1+/− mice. Thus, SNJ1945 is a potential drug for the treatment of human lissencephaly patients.

Original languageEnglish
Article number1224
Pages (from-to)1-10
Number of pages10
JournalScientific reports
Volume3
DOIs
Publication statusPublished - 06-02-2013

All Science Journal Classification (ASJC) codes

  • General

Fingerprint

Dive into the research topics of 'Post-natal treatment by a blood-brain-barrier permeable calpain inhibitor, SNJ1945 rescued defective function in lissencephaly'. Together they form a unique fingerprint.

Cite this